Fig. 4.
Recruitment of SHP-2 phosphatase by CD33 in pervanadate treated cells.
Mo7e, U937, or THP-1 cells (1 × 107) were treated with the phosphatase inhibitor pervanadate, lysed, and immunoprecipitated as in Figure 3. The immunoprecipitates were blotted with anti-SHP-2.
